Hormone replacement therapy and cervical cancer: a systematic review of the literature
Virginia Vargiu(Università Cattolica del Sacro Cuore), Paola Villa(Università Cattolica del Sacro Cuore), Luigi Carlo Turco, Giorgia Dinoi(Agostino Gemelli University Polyclinic), Andrea Rosati(Agostino Gemelli University Polyclinic), Vito Andrea Capozzi(University of Parma), Giovanni Scambia(Agostino Gemelli University Polyclinic)
Cited by 53
Related Papers
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial
|The Lancet Oncology|2021|412
Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta‐analysis
|Ultrasound in Obstetrics and Gynecology|2017|299
ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease
|Annals of Oncology|2024|277
Uterine serous carcinoma
|Gynecologic Oncology|2021|158